生命科学资讯
生物技术与制药领域的最新动态
FDA clears Encora Therapeutics’ wearable wrist device for essential tremor
What were the biggest clinical trial flops of 2025?
After R&D head exits, Immunocore CEO pairs ambition with caution for growing cancer portfolio
Gilead gets cancer drug from China-based Genhouse for $80M upfront
Pentagon adds, then withdraws, WuXi AppTec to Chinese military list
Lilly appeals retatrutide classification ruling in case that could impact compounders
In the clinic for Feb. 13, 2026
Other news to note for Feb. 13, 2026
Regulatory actions for Feb. 13, 2026
Money raised by biopharma
Biopharma money raised: Jan. 1-Feb. 12, 2026
Why Is 10x Genomics (TXG) Stock Soaring Today - FinancialContent
Epigenetic editing startup Moonwalk shifts focus to siRNA for obesity
《蛇梯棋》——赛诺菲CEO惊人换帅
Chutes & Ladders—Sanofi's stunning CEO switch
Integra LifeSciences削减职位，新泽西州普林斯顿站点65名员工受影响。
Integra LifeSciences cuts roles as 65 staffers impacted from Princeton, N.J., site
Moderna 2025年研发支出锐减31%，源于重大管线重组。
Moderna R&D spend shrunk 31% in 2025 amid major pipeline reorg
Lyell starts first-of-its-kind CAR-T trial; New coalition aims to boost European biotechs
灵北偏头痛预防药物二期试验成功，推动新疗法类别进展。
Lundbeck migraine prevention drug succeeds in Phase 2, advancing new therapy class
Moderna流感疫苗困境令2028年盈亏平衡指引蒙上阴影。
Moderna's flu shot dilemma muddies 2028 break-even guidance